Boceprevir Use in Fran A Markov Model of Disease Progression and Cost-Effectiveness for Chronic Hepatitis C (Virus G1)
Abstract
Authors
S Ferrante E.H. Elbasha T. Poynard G. Boyaval
S Ferrante E.H. Elbasha T. Poynard G. Boyaval
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now